Autoantibodies targeting intracellular proteins involved in key processes are detected in patients with idiopathic inflammatory myopathies. These myositisspecific autoantibodies have been increasingly demonstrated to correlate with distinct clinical phenotypes within the myositis spectrum. This review highlights the clinical associations of the myositisspecific autoantibodies, with particular attention to the recently identified and characterized novel myositis autoantibodies: p155/140, p140 (MJ), CADM-140 (MDA5), SAE, and 200/100. © 2011 BioMed Central Ltd.
CITATION STYLE
Betteridge, Z. E., Gunawardena, H., & McHugh, N. J. (2011, March 18). Novel autoantibodies and clinical phenotypes in adult and juvenile myositis. Arthritis Research and Therapy. https://doi.org/10.1186/ar3275
Mendeley helps you to discover research relevant for your work.